ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Interactive Brokers

Interactive Brokers
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Premium IconPremium Help Menu
S&P 500
5,976.97
-1.13%
US Tech 100
21,079.20
-1.25%
Dow Jones
42,197.79
-1.79%
Brent Oil
73.815
0.00%
Bitcoin
105,034.91
-1.04%
Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ

  6. Erasca Inc (ERAS) Quote

Erasca Inc

Erasca Inc (ERAS)

NASDAQ
1.48
-0.05
(-3.27%)
Closed June 14 4:00PM
15 min delayed - Upgrade to Realtime
1.46
-0.02
(-1.35%)
After Hours: 7:51PM
15 min delayed - Upgrade to Realtime

Empower your portfolio: Real-time discussions and actionable trading ideas.

Premium

Key stats and details

Current Price
1.46
Bid
1.44
Ask
1.60
Volume
1,456,770
1.445 Day's Range 1.59
1.01 52 Week Range 3.45
Market Cap
413.6M
Previous Close
1.53
Open
1.49
Last Trade
40
@
1.4409
Last Trade Time
Financial Volume
$ 2,175,308
VWAP
1.4932
Average Volume (3m)
1,775,499
Shares Outstanding
283,287,382
Dividend Yield
-
PE Ratio
-2.59
Earnings Per Share (EPS)
-0.57
Revenue
-
Net Profit
-161.65M

About Erasca Inc

Erasca Inc is a clinical-stage precision oncology company singularly focused on discovering, developing, and commercializing therapies for patients with RAS/MAPK pathway-driven cancers. The company's pipeline includes two clinical-stage programs (ERK and SHP2 inhibitors), two preclinical-stage progr... Erasca Inc is a clinical-stage precision oncology company singularly focused on discovering, developing, and commercializing therapies for patients with RAS/MAPK pathway-driven cancers. The company's pipeline includes two clinical-stage programs (ERK and SHP2 inhibitors), two preclinical-stage programs (CNS-penetrant KRAS G12C and EGFR inhibitors), and seven discovery-stage programs targeting other key oncogenic drivers. Show more

Sector
Pharmaceutical Preparations
Industry
Pharmaceutical Preparations
Website
www.erasca.com
Headquarters
Wilmington, Delaware, USA
Founded
-
Erasca Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker ERAS. The last closing price for Erasca was $1.53. Over the last year, Erasca shares have traded in a share price range of $ 1.01 to $ 3.45.

Erasca currently has 283,287,382 shares outstanding. The market capitalization of Erasca is $433.43 million. Erasca has a price to earnings ratio (PE ratio) of -2.59.

Ask ADVFN Intelligence (AI)

ERAS Latest News

More News

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Edgar (US Regulatory)
May 13 2025
ERAS (-3.27%)

Form 8-K - Current report
Edgar (US Regulatory)
May 13 2025
ERAS (-3.27%)

Form ARS - Annual Report to Security Holders
Edgar (US Regulatory)
April 29 2025
ERAS (-3.27%)

Form DEF 14A - Other definitive proxy statements
Edgar (US Regulatory)
April 29 2025
ERAS (-3.27%)

Form 144 - Report of proposed sale of securities
Edgar (US Regulatory)
April 15 2025
ERAS (-3.27%)

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Edgar (US Regulatory)
March 20 2025
ERAS (-3.27%)

Form 8-K - Current report
Edgar (US Regulatory)
March 20 2025
ERAS (-3.27%)

Form 144 - Report of proposed sale of securities
Edgar (US Regulatory)
March 17 2025
ERAS (-3.27%)

Form 144 - Report of proposed sale of securities
Edgar (US Regulatory)
February 18 2025
ERAS (-3.27%)
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1-0.14-8.751.61.6751.4512659071.58905434CS
40.2217.74193548391.241.71.0616017341.40912583CS
12-0.01-0.6802721088441.471.71.0117754991.35247348CS
26-1.17-44.48669201522.632.841.0115328371.59201271CS
52-0.77-34.52914798212.233.451.0117389542.25328463CS
156-3.74-71.92307692315.210.741.0111894202.87974019CS
260-14.44-90.817610062915.924.471.0110392054.15294404CS

ERAS - Frequently Asked Questions (FAQ)

What is the current Erasca share price?
The current share price of Erasca is $ 1.46
How many Erasca shares are in issue?
Erasca has 283,287,382 shares in issue
What is the market cap of Erasca?
The market capitalisation of Erasca is USD 433.43M
What is the 1 year trading range for Erasca share price?
Erasca has traded in the range of $ 1.01 to $ 3.45 during the past year
What is the PE ratio of Erasca?
The price to earnings ratio of Erasca is -2.59
What is the reporting currency for Erasca?
Erasca reports financial results in USD
What is the latest annual profit for Erasca?
The latest annual profit of Erasca is USD -161.65M
What is the registered address of Erasca?
The registered address for Erasca is 251 LITTLE FALLS DRIVE, WILMINGTON, DELAWARE, 19808
What is the Erasca website address?
The website address for Erasca is www.erasca.com
Which industry sector does Erasca operate in?
Erasca operates in the PHARMACEUTICAL PREPARATIONS sector

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
RBNERobin Energy Ltd
$ 13.85
(313.43%)
101.81M
OPOceanPal Inc
$ 1.63
(125.45%)
80.28M
LGHLWLion Group Holding Ltd
$ 0.0052
(116.67%)
6.87M
NEONNeonode Inc
$ 16.83
(68.47%)
4.78M
ICONIcon Energy Corporation
$ 2.90
(62.01%)
59.04M
SBETSharpLink Gaming Inc
$ 9.2275
(-71.63%)
41.92M
AIHSSenmiao Technology Ltd
$ 0.381
(-63.01%)
16.8M
CHSNChanson International Holding
$ 0.22
(-60.00%)
15.15M
KWMK Wave Media Ltd
$ 2.91
(-50.43%)
2.59M
JZXNJiuzi Holdings Inc
$ 1.56
(-46.39%)
2.24M
HCTIHealthcare Triangle Inc
$ 0.0201
(-33.00%)
856.89M
GNLNGreenlane Holdings Inc
$ 0.0101
(-34.42%)
792.34M
CGBSCrown LNG Holdings Ltd
$ 0.1104
(31.43%)
788.42M
TSLLDirexion Daily TSLA Bull 2X Trust ETF
$ 12.655
(3.81%)
246.13M
NVDANVIDIA Corporation
$ 141.97
(-2.09%)
180.81M

ERAS Discussion

View Posts
glenn1919 glenn1919 2 weeks ago
ERAS................................................https://stockcharts.com/h-sc/ui?s=ERAS&p=W&b=5&g=0&id=p86431144783
👍️0
Monksdream Monksdream 1 month ago
ERAS under $2
👍️0
Monksdream Monksdream 2 months ago
ERAS under $2
👍️0
glenn1919 glenn1919 2 months ago
ERAS...........................https://stockcharts.com/h-sc/ui?s=ERAS&p=W&b=5&g=0&id=p86431144783
👍️0
Monksdream Monksdream 2 months ago
ERAS, under $2
👍️0
glenn1919 glenn1919 9 months ago
ERAS..................................https://stockcharts.com/h-sc/ui?s=ERAS&p=W&b=5&g=0&id=p86431144783
👍️0
glenn1919 glenn1919 10 months ago
ERAS..............................................https://stockcharts.com/h-sc/ui?s=ERAS&p=W&b=5&g=0&id=p86431144783
👍️0
Monksdream Monksdream 11 months ago
ERAS under $3
👍️0
glenn1919 glenn1919 1 year ago
ERAS.....................https://stockcharts.com/h-sc/ui?s=ERAS&p=W&b=5&g=0&id=p86431144783
👍️0
philaya philaya 1 year ago
Got some ...
Gone red,holding.
👍️0
Monksdream Monksdream 1 year ago
ERAS under $3
👍️0
glenn1919 glenn1919 1 year ago
ERAS....................https://stockcharts.com/h-sc/ui?s=ERAS&p=W&b=5&g=0&id=p86431144783
👍️0
Monksdream Monksdream 1 year ago
Been down so long it look like up to me
A crap shoot bet at most 0.001% of your capital
👍️0
ice trader ice trader 1 year ago
What do you like about this play?
👍️0
Monksdream Monksdream 2 years ago
ERAS under $2
👍️0

Your Recent History

NASDAQ
ERAS
Erasca
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub
United States
Company
Business
Popular
Get The App
App Store
Google Play

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2025 ADVFN Ltd - All Rights Reserved

Go Ad-Free

Subscribe to Ad free and enjoy an ad-free experience

No Ads

Try Now

Keep the Ads